COLL vs CVS
Collegium Pharmaceutical Inc (COLL) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the COLL and CVS stock pages for the full models.
Not investment advice.